Member Info for Willowman19

Good find, thank you.

Thank you for your posts soup.

Yes the sp did move nicely recently and those with a low average could make a few quid, that's what it's all about. Good for them!

Personally as a lth, I'm lost for words, like the BOD.

Let's see what happens with this orphan status. I still love the tech and know of people this would help, now!

So progressing nxp002, would make many happy.

We all rolled the dice with NFX, we all know the risk.

Thank you, my user name is Luke Duke.

Regards

Hello, I've tried to find ANA on telegram, without success. Tried Ananda development and Ananda Pharma.

Just bought in, followed this for years.

Got to be in it to win it.

Anyone noticed nuformix plc site is down, and has been since last weds\thursday.

Either a russian cyber attack, or updating?...

We have the IP to treat IPF &PPF, potentially life extending.

Bit of decent kit, potentially nxp002.

Word of the day is potentially.

We have IP that outperforms SOC, and inhalation is apparently the way forward.

Not ramping;).

And what do we want from a potential development partner?

We have IP, and 300k on ze table.

·

Sourced by City girl,

Last day at #ERS2024 in Vienna. Great pleasure talking with partners and contributors to our NXP002 programme - going to be a fascinating period for the progression of IPF and PPF treatments #treatIPF #progress #NXP002

Lee Brothwick from Fibrofind was a speaker who worked on nxp002.

Dan commented on Twitter, he was at Boston networking and seeing how nxp002 fits in with IPF.

Had a reply from Tim Metcalf last week.

I said about expecting a bit of showboating from Dr Dan, Tim replied that people are working hard to progress NFX. Lots going on behind the scenes with nothing ATM that can be made public.

When they can make information public, they will.

NFTs, why are you here???

Thank you Soup;)

Hoping the tide will turn with NFX....

Nice one Taz.

When Anne leaves, we will be flying without wings...

News rich q4 hopefully.

And nxp004, which we don't know much about, yet.